Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ARS Pharmaceuticals Inc (NASDAQ: SPRY) closed the day trading at $11.90 down -5.85% from the previous closing price of $12.64. In other words, the price has decreased by -$5.85 from its previous closing price. On the day, 0.98 million shares were traded. SPRY stock price reached its highest trading level at $12.66 during the session, while it also had its lowest trading level at $11.76.
Ratios:
For a better understanding of SPRY, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.50 and its Current Ratio is at 12.54. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On August 13, 2024, Raymond James Upgraded its rating to Strong Buy which previously was Outperform and also upped its target price recommendation from $18 to $22.
Leerink Partners reiterated its Outperform rating for the stock on August 12, 2024, while the target price for the stock was revised from $19 to $20.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 12 ’24 when Chakma Justin sold 117,333 shares for $12.27 per share. The transaction valued at 1,439,124 led to the insider holds 136,380 shares of the business.
Chakma Justin sold 27,272 shares of SPRY for $328,968 on Dec 13 ’24. The Chief Business Officer now owns 136,380 shares after completing the transaction at $12.06 per share. On Dec 12 ’24, another insider, Dorsey Brian, who serves as the Chief Operating Officer of the company, sold 25,000 shares for $12.30 each. As a result, the insider received 307,432 and left with 6,024 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRY now has a Market Capitalization of 1156507520 and an Enterprise Value of 950162752. For the stock, the TTM Price-to-Sale (P/S) ratio is 423.66 while its Price-to-Book (P/B) ratio in mrq is 5.75. Its current Enterprise Value per Revenue stands at 370.001 whereas that against EBITDA is -15.72.
Stock Price History:
Over the past 52 weeks, SPRY has reached a high of $18.51, while it has fallen to a 52-week low of $5.02. The 50-Day Moving Average of the stock is -18.56%, while the 200-Day Moving Average is calculated to be 4.67%.
Shares Statistics:
Over the past 3-months, SPRY traded about 1.08M shares per day on average, while over the past 10 days, SPRY traded about 1062220 shares per day. A total of 97.15M shares are outstanding, with a floating share count of 50.92M. Insiders hold about 47.60% of the company’s shares, while institutions hold 42.09% stake in the company. Shares short for SPRY as of 1732838400 were 13629789 with a Short Ratio of 12.65, compared to 1730332800 on 12597445. Therefore, it implies a Short% of Shares Outstanding of 13629789 and a Short% of Float of 26.369999999999997.
